Director Glenn P. Muir filed a Form 4 with the SEC on November 18, 2026, disclosing the sale of 175,000 shares of Neuronetics, Inc. common stock on November 16, 2026.

Key Highlights

  • Reporting person: Glenn P. Muir, identified as a Director of Neuronetics, Inc.
  • Transaction: 175,000 shares of common stock disposed of (transaction code A is listed, though the shares are recorded as disposed) at a weighted average price of $1.31 per share on November 16, 2026.
  • Price range: Individual sale prices ranged from $1.25 to $1.385 per share across multiple transactions.
  • Beneficial ownership following transaction: 576,816 shares of common stock held directly.
  • Exchange and ticker: Neuronetics, Inc. trades as NASDAQ:STIM.

Glenn P. Muir's November 2026 Share Transaction at Neuronetics

According to the Form 4 filing, Glenn P. Muir, a Director of Neuronetics, Inc. (NASDAQ:STIM), reported a change in beneficial ownership of the company's common stock dated November 16, 2026. The filing was submitted on November 18, 2026, and covers a single transaction in Table I involving non-derivative securities. Muir's address is listed as c/o Neuronetics, Inc., 3222 Phoenixville Pike, Malvern, Pennsylvania 19355.

The filing discloses that 175,000 shares of common stock were transacted at a weighted average price of $1.31 per share. A footnote in the filing states: "The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.25 to $1.385." The filing further notes that Muir "undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote." Following the reported transaction, Muir's direct beneficial ownership in Neuronetics common stock stands at 576,816 shares, according to the filing.

No derivative securities transactions were reported in Table II of this filing. The form was signed by Francis Brown as Attorney-in-Fact on November 18, 2026. The filing does not indicate that any check box for a Rule 10b5-1(c) written trading plan was selected.

What Was Disclosed

Neuronetics Director Glenn P. Muir disclosed the sale of 175,000 shares of common stock on November 16, 2026, at a weighted average price of $1.31, with individual prices ranging from $1.25 to $1.385, leaving him with 576,816 shares directly held.